Owner Bristol-Myers Squibb Company

Inventors Lee, Francis Y., F.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002248542

PCT Pub. Number WO2002/072085

Priority 60/275,801 14.03.01 US; 60/316,395 31.08.01 US

Filing date 5 March 2002

Wipo publication date 24 September 2002

Acceptance publication date 18 January 2007

C07D 491/044 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/136 (2006.01) - having the amino group directly attached to the aromatic ring, e.g. benzeneamine

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/282 (2006.01)

A61K 31/335 (2006.01) - having oxygen as the only ring hetero atom, e.g. fungichromin

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/365 (2006.01) - Lactones

A61K 31/366 (2006.01) - having six-membered rings, e.g. delta-lactones

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/475 (2006.01) - having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/704 (2006.01)

A61K 31/7052 (2006.01)

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 13/10 (2006.01) Drugs for disorders of the urinary system

A61P 35/00 (2006.01) Antineoplastic agents